PP_1170x120_10-25-21

PCMA

PCMA calls for expanding COVID-19 “Test to Treat” protocols to include pharmacists

PCMA calls for expanding COVID-19 “Test to Treat” protocols to include pharmacists

WASHINGTON — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement supporting the policy of one-stop COVID-19 testing and treatment at pharmacies and calling on the Biden Administration to expand the scope of its recently-announced “Test to Treat” program: “We applaud the Biden administration on its efforts to increase

PCMA makes statement on the Senate Finance Committee hearing on Rx drug prices in Medicare

PCMA makes statement on the Senate Finance Committee hearing on Rx drug prices in Medicare

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott released the following statement on today’s Senate Finance Committee hearing, “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.” “PCMA commends the Senate Finance Committee for holding this important hearing on drug price inflation. We share the committee’s goal

PCMA issues statement on the Pre-Approval Information Exchange Act

PCMA issues statement on the Pre-Approval Information Exchange Act

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott today issued the following statement on H.R. 7008, the Pre-approval Information Exchange (PIE) Act: “The introduction of the PIE Act is an important step forward in establishing a value-based health care system. We applaud Rep. Brett Guthrie (R-KY) for his longtime focus on

PCMA issue statement on the 2023 Medicare Part D proposed rule

PCMA issue statement on the 2023 Medicare Part D proposed rule

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the 2023 Medicare Part D proposed rule from the Centers for Medicare & Medicaid Services (CMS): “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they would significantly increase Medicare

PCMA issues statement on passage of the Bipartisan Infrastructure Package

PCMA issues statement on passage of the Bipartisan Infrastructure Package

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on Congress’ passage of the Bipartisan Infrastructure Package: “We applaud Congress for passing the infrastructure legislation, which, when signed into law, will enact a three-year delay of the Medicare Part D rebate rule. There is no question that the rebate

PCMA issues statement on drug pricing agreement in the budget bill

PCMA issues statement on drug pricing agreement in the budget bill

WASHINGTON — Pharmaceutical Care Management Association (PCMA) Ppresident and CEO JC Scott issued the following statement on Congress’ agreement on drug pricing language for the budget bill: “We appreciate congressional negotiators’ focus on prescription drug prices and applaud inclusion of repeal of the rebate rule, a rule which threatens to dramatically increase premiums for Medicare

PCMA: Senator Braun’s proposed infrastructure amendment hurts seniors, increases taxpayer costs

PCMA: Senator Braun’s proposed infrastructure amendment hurts seniors, increases taxpayer costs

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the proposed amendment by Senator Mike Braun (R, Ind.) in the Bipartisan Infrastructure Framework (BIF) legislation: “The Senate’s inclusion of a provision to delay the Medicare rebate rule in the infrastructure legislation is a good start to full

Pharmacy groups ready for another legal fight with the PBMs in North Dakota

Pharmacy groups ready for another legal fight with the PBMs in North Dakota

ALEXANDRIA, Va. – A group of nine pharmacy associations filed a friend of the court (amicus curiae) brief in the Eighth Circuit of the U.S. Court of Appeals today defending North Dakota’s right to regulate pharmacy benefit managers (PBMs). The parties to the amicus brief are the National Community Pharmacists Association (NCPA) and the American Pharmacists

PCMA files motion to vacate effective date for rebate rule

PCMA files motion to vacate effective date for rebate rule

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has filed a motion for summary judgment to vacate the effective date of the Trump Administration’s rebate rule. The motion for summary judgment, filed in the U.S. District Court for the District of Columbia, seeks to vacate the January 1, 2022 effective date for the rebate rule

Study: Powerful PSAOs negotiate on behalf of independent pharmacies

Study: Powerful PSAOs negotiate on behalf of independent pharmacies

WASHINGTON — A new report, “Pharmacy Services Administrative Organizations (PSAOs) and their Little-Known Connection to Independent Pharmacies,” sheds light on the role of PSAOs in the prescription drug supply and payment chain. The white paper, researched and written by the health care policy consulting firm Health Evaluations and released by the Pharmaceutical Care Management Association

PCMA: Finalizing ‘Rebate Rule’ will increase premiums, taxpayer cost

PCMA: Finalizing ‘Rebate Rule’ will increase premiums, taxpayer cost

WASHINGTON— Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration and Health and Human Services (HHS) Secretary Alex Azar finalizing the rebate rule (Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection): “Simply put, the HHS Secretary’s

PCMA issues statement on 2020 election results

PCMA issues statement on 2020 election results

WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the

New report confirms proposed “rebate rule” would raise Medicare premiums and taxpayer costs

New report confirms proposed “rebate rule” would raise Medicare premiums and taxpayer costs

WASHINGTON — A new report, “Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent evidence showing that prescription drug rebates negotiated by pharmacy benefit managers (PBMs) reduce drug costs and lower premiums in Medicare Part D. The paper concludes that proposed government action to

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has

1 2 3